🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
Non-Nutrient/Non-Botanical Product Type
33% Evidence Coverage

Supplement Facts — Evidence Check

Calories
1 Calorie(s)
Total Carbohydrates
0.6 Gram(s) (1% DV)
5 mg
📊 Market median: 3.0mg (984 products) 📚 236 studies (Tier A: 2, B: 109)
This product: 5mg UL 10mg

Other Ingredients

natural Raspberry flavor natural Strawberry flavor EarthSweet Stearic Acid Vegetable Magnesium Stearate

Label Claims — Verification

All Other
Structure/Function
All Other (100% of products) Structure/Function (86% of products) Nutrient (7% of products)

Target Groups

Children 4 or More Years of Age Vegan Vegetarian Adult (18 - 50 Years) Kosher Gluten Free Dairy Free

Product Information

📋 Directions for Use

Directions: As a dietary supplement, take one chewable tablet 30 to 60 minutes before bedtime or as directed by a healthcare practitioner.

⚠️ Warnings & Precautions

Warning: Not for long-term use or for children under 12 years of age.

If you suffer from chronic sleeplessness and/or are taking prescription medications, such as tranquilizers, sedatives, or antidepressants like MAO inhibitors, consult with your healthcare practitioner before use. Do not use this product if you are pregnant, trying to conceive or breastfeeding.

Residual drowsiness may occur, so refrain from operating machinery or driving a vehicle when taking this product.

🧪 Formulation Notes

Bluebonnet’s EarthSweet Chewables Melatonin 5 mg Tablets help promote restful sleep for those affected by disturbed sleep/wake cycles, such as those traveling across multiple time zones. This product is sweetened with EarthSweet, a proprietary sweetening mix of juice concentrates and cane crystals.

Made with non-GMO ingredients

Vegan

Free of milk, egg, fish, crustacean shellfish, tree nuts, peanuts, wheat and soybeans. Also free of yeast, gluten, barley, rice and sodium.

Bluebonnet’s KOF-K Certification #K-0000700

Additional Information

Available in chewable tablets for maximum assimilation and absorption.

Made with non GMO ingredients Vegan K Parve Gluten free

Product Details

UPC / SKU 7 43715 00997 4
DSLD Entry Date 2019-07-24
Product Type Non-Nutrient/Non-Botanical
Form Tablet or Pill
DSLD ID 204838
Data Updated 2026-04-11

Research Evidence

291 Research Sources
55 Avg Quality Score
129 Meta Analysis
93 Systematic Review
51 Rct
11 Clinical Trial
2 Other
2 Regulatory Source
1 Openfda Safety
A Interventions for preventing delirium in hospitalised non-ICU patients
Meta Analysis The Cochrane database of systematic reviews 2016
A Melatonin for preoperative and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2020
A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2022
B Pharmacological interventions for prevention of weight gain in people with schizophrenia
Meta Analysis The Cochrane database of systematic reviews 2022
B Melatonin for pre- and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2015
B Prevention of depression in adults with long-term physical conditions
Meta Analysis The Cochrane database of systematic reviews 2021
B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Systematic Review Lancet (London, England) 2022
B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis
Meta Analysis BMJ open 2023
B Second-generation antidepressants for preventing seasonal affective disorder in adults
Meta Analysis The Cochrane database of systematic reviews 2015
B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Meta Analysis The Cochrane database of systematic reviews 2021
View all evidence for Melatonin →

Compare Similar Products

View all Melatonin products →